SEC Filing Details

Document Details

Form
Filing Date
Nov 12, 2020
Document Date
Nov 12, 2020
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Sensei Biotherapeutics, Inc
Issuer
SENSEI BIOTHERAPEUTICS, INC.

HQ: 1405 Research Blvd, Suite 125, Rockville, MD 20850

MA: 22 Boston Wharf Rd, 7th Floor,
Boston, MA 02210